首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

市場調查報告書

商品編碼

1736721

全球深層腦部刺激器市場規模（依產品類型、應用、最終用戶、區域範圍和預測）

Global Deep Brain Stimulation Devices Market Size By Product Type, By Application, By End-User, By Geographic Scope And Forecast

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄

深層腦部刺激器市場規模及預測

深層腦部刺激器市場規模預計在 2023 年達到 14.6 億美元，到 2032 年將達到 27.7 億美元，2026 年至 2032 年的複合年成長率為 9.20%。

深層腦部刺激器(DBS) 是醫療設備。這些設備與脈衝發生器相連，通常植入於胸部皮下。 DBS 通常用於控制異常腦部活動，可有效治療多種神經系統疾病。

肌張力不全症刺激 (DBS) 常用於治療神經系統疾病，尤其是帕金森氏症和肌張力不全症。對於帕金森氏症，DBS 可減輕震顫、僵硬和心搏過緩等運動症狀，顯著改善患者的生活品質。對於肌張力失調，DBS 可抑制不自主肌肉收縮，進而達到運動控制。 DBS 也正在被研究用於強迫性精神官能症(OCD)、癲癇和重度憂鬱症疾病，這進一步增強了其治療潛力。

深層腦部刺激器(DBS) 的未來應用或將擴展至治療更廣泛的神經和精神疾病，包括癲癇、重度憂鬱症和強迫性精神官能症(OCD)。目前，相關研究正在不斷完善刺激技術，並開發能夠即時回應腦部活動的自適應 DBS 系統，以增強治療效果。此外，神經影像學和個人化醫療的進步有望實現客製化的刺激通訊協定，從而改善患者預後並減少傳統 DBS 療法相關的副作用。

全球深層腦部刺激器市場動態

影響全球深層腦部刺激器市場的關鍵市場動態是：

關鍵市場促進因素

神經系統疾病盛行率不斷上升：帕金森氏症、癲癇和肌張力不全症等神經系統疾病盛行率不斷上升，推動了對深部腦電刺激 (DBS) 設備的需求。隨著人口老化，這些疾病的盛行率預計將上升，從而增加對有效替代療法的需求。 DBS 已被證明有助於緩解症狀並改善患者的生活品質，從而擴大了市場。

技術進步：深部腦電刺激 (DBS) 技術的創新，包括更複雜設備和更精細刺激方法的開發，正在提高治療的有效性和安全性。能夠根據腦活動即時調整刺激的自適應 DBS 設備的開發是一項重要成就。此類技術正在改善患者預後，同時最大限度地減少不良反應，使 DBS 成為患者和醫護人員更理想的治療選擇。

深部腦電刺激 (DBS) 療法的認知度和接受度不斷提升：醫療保健專業人員和患者對 DBS 療法益處的認知度不斷提升，推動了市場擴張。相關教育計畫和宣傳活動使人們更了解治療過程，從而提高了接受度。隨著越來越多的患者尋求藥物治療的替代方案，尤其是在治療手段有限的患者中，對 DBS 設備的需求不斷成長，從而推動了市場成長。

主要問題

治療費用高昂：DBS 治療的主要挑戰之一是高昂的費用。許多患者不僅無力負擔設備購買費用，還可能無法負擔手術植入和後續治療費用。這一巨大的經濟障礙通常會限制 DBS 的治療，尤其是在醫療資源有限的新興國家。 DBS 的保險覆蓋範圍各不相同，患者可能難以獲得報銷，從而限制了他們獲得治療的機會。

監管障礙：深部腦電刺激 (DBS) 設備的法規核准流程漫長而複雜。製造商必須遵循嚴格的規定，並進行全面的臨床測試以證明其安全性和有效性，這可能會導致產品上市延遲並增加開發成本。此外，各國監管規範的差異也進一步加劇了複雜性，使企業難以在國際市場上銷售產品。

臨床限制和風險：儘管已證實深部腦電刺激 (DBS) 對某些疾病有效，但由於合適患者數量不足以及手術可能存在的風險，其應用受到限制。並非所有患者對 DBS 反應良好，部分患者可能會出現感染、設備故障和神經系統問題等副作用。這些臨床局限性可能會阻礙患者和醫療保健專業人員將 DBS 作為治療選擇，從而影響市場成長。

主要趨勢

技術進步：最顯著的趨勢之一是深部腦部電刺激 (DBS) 技術的快速發展。能夠根據即時腦活動調整刺激的閉合迴路系統正變得越來越普遍。這些設備透過根據患者的獨特需求提供精準的電脈衝來最佳化治療，從而有可能改善療效並最大限度地減少副作用。此外，電極設計和材料的進步也提高了深部腦電刺激 (DBS) 設備的有效性和耐用性。

用途不斷拓展：另一個關鍵進展是DBS的應用範圍不斷擴展，超越了典型的使用案例。雖然DBS主要用於治療帕金森氏症和肌張力不全症，但研究人員也在探索其治療一系列神經和精神疾病的潛力，包括強迫性精神官能症(OCD)和重度憂鬱症。這種應用範圍的廣泛性正在推動需求，並為市場成長創造新的機會。

認知度與接受度的提升：隨著人們對深部腦電刺激（DBS）作為潛在治療方案的認知度不斷提升，市場成長也日益顯著。教育活動和倡導團體正在大力宣傳DBS的益處，從而提升了醫療專業人士和患者的接受度。卓越的臨床療效和患者口碑也印證了這一趨勢，增強了人們對DBS作為一種安全有效治療方法各種疾病的信心。

Deep Brain Stimulation Devices (DBS) are medical devices that send electrical impulses to specific brain regions via implanted electrodes. These devices are linked to a pulse generator which is normally inserted beneath the skin in the chest region. DBS is generally used to control aberrant brain activity which has therapeutic benefits for a variety of neurological diseases.

They are generally used to treat neurological illnesses, specifically Parkinson's disease and dystonia. In Parkinson's disease, DBS reduces motor symptoms such as tremors, stiffness, and bradykinesia, considerably increasing patients' quality of life. DBS can aid with dystonia by reducing involuntary muscle contractions allowing for more movement control. DBS is also being investigated for illnesses such as obsessive-compulsive disorder (OCD), epilepsy, and major depressive disorder, which increases its therapeutic potential.

The future uses of Deep Brain Stimulation Devices (DBS) may expand to treat a wider range of neurological and psychiatric disorders such as epilepsy, major depressive disorder, and obsessive-compulsive disorder (OCD). Research is ongoing to refine stimulation techniques and develop adaptive DBS systems that respond in real-time to brain activity enhancing treatment efficacy. Additionally, advancements in neuroimaging and personalized medicine could enable tailored stimulation protocols improving outcomes for patients and reducing side effects associated with traditional DBS therapies.

Global Deep Brain Stimulation Devices Market Dynamics

The key market dynamics that are shaping the global Deep Brain Stimulation Devices Market include:

Key Market Drivers:

Increasing Prevalence of Neurological Disorders: The increased prevalence of neurological diseases such as Parkinson's disease, epilepsy, and dystonia has fuelled demand for DBS devices. As populations age, the prevalence of these illnesses is predicted to rise, creating a higher demand for effective treatment alternatives. DBS has been shown helpful in treating symptoms and enhancing patients' quality of life, resulting in market expansion.

Technological Advancements: DBS technology innovations, such as the creation of more complex devices and refined stimulation procedures, are improving the treatment's effectiveness and safety. The development of adaptive DBS devices that can modify stimulation in real-time based on brain activity is a significant achievement. These technologies increase patient results while minimising negative effects, making DBS a more desirable option for both patients and healthcare providers.

Growing Awareness and Acceptance of DBS Therapy: Increased awareness among healthcare professionals and patients about the benefits of DBS therapy helps to drive market expansion. Educational programs and advocacy efforts are helping to demystify the treatment process, resulting in more acceptance. As more patients seek alternatives to medication, particularly when treatment is limited, demand for DBS devices rises, promoting market growth.

Key Challenges:

High Cost of Treatment: One of the main challenges is the high expense of DBS therapy. Many patients may be unable to afford the gadgets as well as surgical installation and continuing follow-up care. This significant financial barrier frequently restricts access to DBS, especially in developing countries where healthcare resources are limited. Insurance coverage for DBS varies, and patients may have difficulty receiving reimbursement restricting treatment access.

Regulatory Hurdles: The regulatory licensing process for DBS devices can be lengthy and complicated. Manufacturers must follow strict rules and conduct thorough clinical trials to demonstrate safety and efficacy. This might lead to delayed product introductions and higher development expenditures. Furthermore, various regulatory norms across countries add another layer of complexity making it difficult for companies to market their products internationally

Clinical Limitations and Risks: While DBS has shown beneficial for some illnesses, its use is limited because of a lack of appropriate patients and the possible hazards involved with surgery. Not all patients respond well to DBS, and some may develop side effects including infection, device malfunction, or neurological problems. These clinical constraints may dissuade patients and healthcare professionals from using DBS as a therapeutic option affecting market growth.

Key Trends:

Technological Advancements: One of the most noteworthy trends is the rapid development of DBS technology. Closed-loop systems which adapt stimulation to real-time brain activity, are becoming more common. These devices can optimize treatment by delivering precise electrical impulses suited to the patient's specific needs, potentially boosting outcomes while minimising negative effects. Furthermore, advances in electrode design and materials improve the efficacy and durability of DBS devices.

Increasing Applications: Another key development is the growth of DBS applications beyond their typical use cases. While DBS has predominantly been used to treat Parkinson's disease and dystonia, researchers are also investigating its potential for treating various neurological and psychiatric diseases such as epilepsy, obsessive-compulsive disorder (OCD), and major depressive disorder. This expanded breadth is increasing demand and creating new opportunities for market growth.

Growing Awareness and Acceptance: Increased knowledge of DBS as a potential treatment option is also driving market growth. Educational activities and advocacy groups are publicising the benefits of DBS, resulting in increased acceptability among healthcare professionals and patients. This trend is supported by excellent clinical outcomes and patient testimonials that promote faith in DBS as a safe and effective treatment for a variety of disorders

Global Deep Brain Stimulation Devices Market Regional Analysis

Here is a more detailed regional analysis of the global Deep Brain Stimulation Devices Market:

North America:

North America dominates the deep brain stimulation (DBS) devices market due to its advanced healthcare infrastructure and strong expenditure in R&D. The presence of significant medical equipment manufacturers and cutting-edge technological advancements helps to accelerate the development of sophisticated DBS systems. Furthermore, the region has a strong regulatory structure that facilitates the approval and commercialization of medical devices enabling the availability of high-quality treatment choices for individuals with neurological illnesses.

Furthermore, the rising prevalence of disorders including Parkinson's disease, epilepsy, and depression in North America increases demand for DBS therapy. Growing awareness among healthcare professionals and patients about the usefulness of DBS in controlling various illnesses helps to drive market expansion. Collaboration among healthcare providers, researchers, and manufacturers creates a favorable climate for clinical trials and product introductions reinforcing North America's dominant position in the worldwide DBS device industry.

Asia-Pacific:

Asia Pacific is the fastest-growing region in the deep brain stimulation (DBS) devices market, owing to several factors including the rising prevalence of neurological illnesses such as Parkinson's disease, epilepsy, and depression. As the population ages, the prevalence of these disorders rises generating the need for effective treatments such as DBS. Furthermore, improved healthcare infrastructure in countries such as China and India increases access to innovative medical technologies which drives market growth.

Furthermore, the region is seeing tremendous investment in R&D, which is driving advancements in DBS technology. Governments and the commercial sector are working to promote neuromodulation medicines which are critical to improving patient outcomes. Increased awareness of DBS among healthcare professionals and patients combined with favorable reimbursement regulations is also helping to drive the market in Asia Pacific. This combination of increased demand, technological developments, and supporting healthcare regulations places Asia Pacific as a market leader for DBS devices.

Global Deep Brain Stimulation Devices Market: Segmentation Analysis

The Deep Brain Stimulation Devices Market is segmented based on Product Type, Application, End-User, and Geography.

Deep Brain Stimulation Devices Market, By Product Type

Single-channel Deep Brain Stimulator
Dual-channel Deep Brain Stimulator

Based on the Product Type, the Global Deep Brain Stimulation Devices Market is bifurcated into Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator. The dual-channel deep brain stimulator is more dominant in the Deep Brain Stimulation Devices Market. This dominance stems from its ability to target multiple brain regions simultaneously offering more effective treatment for complex neurological conditions. By allowing for independent programming of each channel, dual-channel stimulators enhance therapeutic outcomes and provide greater customization for patient needs. This versatility and improved efficacy make dual-channel devices the preferred choice among healthcare providers contributing to their increased market share over single-channel stimulators.

Deep Brain Stimulation Devices Market, By Application

Parkinson's Disease
Essential Tremor
Dystonia
Epilepsy
Others

Based on Application, the Global Deep Brain Stimulation Devices Market is bifurcated into Parkinson's Disease, Essential Tremor, Dystonia, Epilepsy, and Others. In the Deep Brain Stimulation (DBS) Devices market, Parkinson's Disease is the most dominant indication. The significant prevalence of Parkinson's disease, along with its challenging motor symptoms such as tremors and rigidity, drives the demand for DBS as an effective treatment option. Additionally, the established efficacy of DBS in alleviating symptoms of Parkinson's enhances its adoption among healthcare providers. While other conditions like Essential Tremor and Dystonia also contribute to the market, Parkinson's remains the leading focus for DBS applications.

Deep Brain Stimulation Devices Market, By End-User

Hospitals
Ambulatory Surgical Centers
Neurological Clinics
Others

Based on the End-User, the Global Deep Brain Stimulation Devices Market is bifurcated into Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Others. Hospitals are the most dominant segment in the Deep Brain Stimulation Devices Market. They offer comprehensive neurological care, including specialized surgical procedures and post-operative support for patients undergoing deep brain stimulation. The presence of advanced medical facilities and experienced healthcare professionals in hospitals ensures proper device implantation and patient management. Additionally, hospitals are often involved in clinical trials and research contributing to advancements in DBS technology and treatment protocols which further solidifies their leading position in the market.

Deep Brain Stimulation Devices Market, By Geography

North America
Europe
Asia Pacific
Rest of the world

Based on Geography, the Global Deep Brain Stimulation Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is more dominant in the deep brain stimulation (DBS) devices market due to advanced healthcare infrastructure, significant investment in research and development, and a high prevalence of neurological disorders such as Parkinson's disease and epilepsy. The presence of key market players and innovative technologies in the region fosters rapid advancements in DBS solutions. Additionally, favorable reimbursement policies and increasing awareness of DBS therapies among healthcare professionals and patients contribute to the growing adoption of these devices in North America.

Key Players

The "Global Deep Brain Stimulation Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, LivaNova PLC, Aleva NeuroTechnologies, Beijing PINS Medical Co., Ltd, SceneRay Co Ltd., and Michigan Tech Researchers.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Deep Brain Stimulation Devices Market Key Developments

In June 2020, Percept, a deep brain stimulation device from Medtronic, was approved by the FDA. Brain Sense technology is used by the company to continuously capture, record, and monitor brain signals in individuals with neurological diseases. It has the potential to aid clinicians in tracking patient brain activity and enhancing data-driven, tailored neurostimulation treatment.
In 2021, Abbott, received FDA approval for its new rechargeable deep brain stimulation system, the Liberta RC, which is noted for being the smallest and having the longest battery life among DBS devices. This innovation aims to enhance patient comfort and convenience by reducing the frequency of recharges.

1 INTRODUCTION OF GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY PRODUCT TYPE

5.1 Overview
5.2 Single-channel Deep Brain Stimulator
5.3 Dual-channel Deep Brain Stimulator

6 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET., BY APPLICATION

6.1 Overview
6.2 Parkinson's Disease
6.3 Essential Tremor
6.4 Dystonia
6.5 Epilepsy
6.6 Others

7 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY END-USER

7.1 Overview
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Neurological Clinics
7.5 Others

8 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Boston Scientific Corporation
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Medtronic Plc
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Abbott Laboratories
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 NeuroPace Inc
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Renishaw Plc
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Beijing PINS Medical Co. Ltd
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 LivaNova PLC
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Nexstim
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Aleva Neurotherapeutics
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 St. Jude Medical
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments